CClinicalTrials.gg
Sign In
CompletedNCT01716091Updated Jan 7, 2015

The Effect of Saline Irrigation in the Peritoneal Cavity at Cesarean Delivery

An observational study in Postoperative Enfectious Morbidity and Postoperative GİS Functionally Recovery, sponsored by Istanbul Bakirkoy Maternity and Children Diseases Hospital. Completed at 1 site in Turkey. Open to female participants aged 18 Years to 44 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-01-07.

Sponsored by Istanbul Bakirkoy Maternity and Children Diseases Hospital · Observational

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
430
Ages
18 Years to 44 Years
Sex
Female
01

Study summary

The investigators hypotheised that irrigating the abdominal cavity with saline at the time of cesarean delivery will increase Gastrointestinal System Disfunction without maternal infectious morbidity(especially febril morbidity).

02

Conditions studied

  • Postoperative Enfectious Morbidity
  • Postoperative GİS Functionally Recovery

Keywords

  • focus of study is postoperative enfectious morbidity and postoperative GİS functionally recovery
03

In context

Lead sponsor

Istanbul Bakirkoy Maternity and Children Diseases Hospital is the lead sponsor of 10 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 44 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

all pregnant women between 18 years or older and who requıred cesarean delivery.

Inclusion criteria

  1. Elective cesarean delivery
  2. Gestational age greater 38 weeks

Exclusion criteria

Exclusion Criteria:

  1. chorioamnıonıtıs
  2. type 1 diabetes mellitus
  3. placenta previa and acreata
  4. prior severe gastrointestional disease
  5. emergency cesarean delivery
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
430 participants (actual)

Groups and cohorts

  • saline irrigation

    irrigation group:saline irrigation after uterine wall closed control group:no irrigation after uterine wall closed

    Procedure: irrigation in the peritoneal cavity

Interventions

  • Procedureirrigation in the peritoneal cavity

    irrigation in the peritoneal cavity after uterine wall closed at cesarean

06

What researchers measure

Primary outcomes

  1. postoperative gastrointestinal system disturbance

    ıntraoperative and postoperative nausea,emesiz and requirement antıemetic drug

    Time frame: postoperativeone weeks

Secondary outcomes

  1. postoperative febril morbidity

    postoperative endometritis,febril morbidity

    Time frame: postoperative six weeks

07

Study locations

1 site
  • T.C. Kanuni Sultan Süleyman Teaching Hospital
    Halkalı/İstanbul, Küçükçekmece 34105, Turkey
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 7, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01716091
Lead sponsor
Istanbul Bakirkoy Maternity and Children Diseases Hospital
Responsible party
Osman Aşıcıoğlu (T.C. Şişli Etfal E A H, Istanbul Bakirkoy Maternity and Children Diseases Hospital) — Principal investigator
First posted
Oct 29, 2012
Start date
Nov 2012
Primary completion
Aug 2014
Completion
Oct 2014
Last update
Jan 7, 2015

Study contacts

Osman Aşıcıoğlu, M.D.
principal investigator · T.C. Kanuni Sultan Süleyman Teaching Hospital

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Istanbul Bakirkoy Maternity and Children Diseases Hospital

Start the discussion